Kenny Carmody: “That is not a cynical observation. It is the foundational economic logic of the pharmaceutical industry stated plainly. A patient cured is a customer lost. A patient managed, returning monthly for the prescription that addresses the symptom without resolving the cause, is a revenue stream that compounds over a lifetime. The repeat business model is not a flaw in the system. It is the system.”
“There Is No Money in Cures”
Published by markskidmore
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times. View more posts